Beverley Lim Høeg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Beverley Lim Høeg has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
- Christoffer Johansen
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Oncology, CASTLE, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Vejle Hospital, University of Southern Denmark, Vejle, Denmark
13 shared publications - Pernille Envold Bidstrup
Psychological Aspects of Cancer, Danish Cancer Institute, Copenhagen, Denmark
13 shared publications - Susanne Oksbjerg Dalton
Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark
11 shared publications Pernille Envold Bidstrup
Psychological Aspects of Cancer, Cancer Survivorship, Danish Cancer Institute, Strandboulevarden 49, 2100, Copenhagen, Denmark
9 shared publications- Lena Saltbæk
Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Ny Østergade 16, Roskilde, DK-4000, Denmark
5 shared publications Susanne Oksbjerg Dalton
Cancer Survivorship Danish Cancer Institute , Copenhagen, Denmark
5 shared publications
Latest Publications
- 23 September 2026
- Published by Springer Nature in European Journal of Epidemiology
- p. 1-14
Survival in children and adolescents with life-limiting conditions–a nationwide cohort study
There is an increasing prevalence of children and adolescents with life-limiting conditions (LLC) with potential need for supportive and palliative care, but their survival has never been investigated. We aimed to investigate the survival of children and adolescents with LLC and potential factors for poor prognosis through a registry-based nationwide cohort study. We included all patients aged 0-21 years, born in Denmark and diagnosed with an LLC between January 1, 1995 and December 31, 2021. Kaplan-Meier survival curves were plotted across disease groups. Regression models with 1-year and 10-year restricted mean survival time as outcomes were used to investigate factors for poor prognosis including child sex, age, parental education and diagnostic period. We identified 102,793 children and adolescents with a total of 116,599 LLC (10.8% had >1 diagnosis). Median follow-up time was 9.85 years (interquartile range 5.15, 16.05) with 5728 deaths. Most deaths occurred within one year of diagnosis. Overall 1-year and 10-year survival rates were 95.6% and 94.5% respectively. In children <1 year, the poorest overall survival was seen in children with metabolic diseases before 2010 and neurologic diseases after 2010. In children ≥1 year, the poorest overall survival was seen in those with malignancy diseases regardless of diagnostic period. Children <1 year, with multiple concurrent diagnoses, parents with shorter educations, and diagnosed before 2010 had the shortest survival times. Most children and adolescents with LLC live for many years with illness. Thus, it is important to clarify their need for supportive and palliative care, along the illness trajectory.
- 23 September 2026
- Published by Springer Nature in European Journal of Epidemiology
- p. 1-14
Survival in children and adolescents with life-limiting conditions–a nationwide cohort study
There is an increasing prevalence of children and adolescents with life-limiting conditions (LLC) with potential need for supportive and palliative care, but their survival has never been investigated. We aimed to investigate the survival of children and adolescents with LLC and potential factors for poor prognosis through a registry-based nationwide cohort study. We included all patients aged 0-21 years, born in Denmark and diagnosed with an LLC between January 1, 1995 and December 31, 2021. Kaplan-Meier survival curves were plotted across disease groups. Regression models with 1-year and 10-year restricted mean survival time as outcomes were used to investigate factors for poor prognosis including child sex, age, parental education and diagnostic period. We identified 102,793 children and adolescents with a total of 116,599 LLC (10.8% had >1 diagnosis). Median follow-up time was 9.85 years (interquartile range 5.15, 16.05) with 5728 deaths. Most deaths occurred within one year of diagnosis. Overall 1-year and 10-year survival rates were 95.6% and 94.5% respectively. In children <1 year, the poorest overall survival was seen in children with metabolic diseases before 2010 and neurologic diseases after 2010. In children ≥1 year, the poorest overall survival was seen in those with malignancy diseases regardless of diagnostic period. Children <1 year, with multiple concurrent diagnoses, parents with shorter educations, and diagnosed before 2010 had the shortest survival times. Most children and adolescents with LLC live for many years with illness. Thus, it is important to clarify their need for supportive and palliative care, along the illness trajectory.
- 16 September 2026
- Published by Wiley in Psycho-Oncology
- Vol. 35 (9) , e70603
“Resilient Caregivers”—A Randomized Trial of a Resilience‐Based Intervention for Psychologically Distressed Partner Caregivers of Patients With Cancer
Background: Intimate partners of cancer patients often experience significant distress. We examined the effectiveness of the “Resilient Caregivers” group intervention for improving psychological outcomes among distressed partner caregivers in a randomized trial ( Clinicaltrials.gov ID: NCT04610034). Methods: Participants were recruited through an oncology department and two cancer counseling centers in Denmark. Partners of patients receiving cancer treatment and experiencing distress (> 4 on the distress thermometer) were eligible and randomized 1:1 to either the intervention or usual care, stratified by sex and age (≤/> 50 years). “Resilient Caregivers” consists of seven manualized sessions developed according to a resilience framework focusing on meta‐reflective skills, coping strategies and values clarification in relation to being a partner of a patient with cancer. Participants completed questionnaires at baseline, 3‐, 6‐ and 12‐months assessing anxiety (primary outcome) and depression, distress, stress, resilience, quality of life and sleep quality. Intervention effects were analyzed using mixed models for repeated measures. Results: Between April 2021 and May 2023, 79 partners were included (39 intervention, 40 control). Most were female (74%), above 50 years old (80%) and had at least a bachelor's degree (86%). There were significant improvements in anxiety at 12 months (mean difference: −2.5, 95% confidence interval: −4.6 to −0.4, p = 0.018), and depression and quality of life at 3 months. Between‐group differences were not significant for other outcomes. Satisfaction was high and participants valued the group format. Conclusions: “Resilient Caregivers” showed encouraging findings and may be a potentially cost‐effective approach to providing support to partner caregivers.
- 16 September 2026
- Published by Wiley in Psycho-Oncology
- Vol. 35 (9) , e70603
“Resilient Caregivers”—A Randomized Trial of a Resilience‐Based Intervention for Psychologically Distressed Partner Caregivers of Patients With Cancer
Background: Intimate partners of cancer patients often experience significant distress. We examined the effectiveness of the “Resilient Caregivers” group intervention for improving psychological outcomes among distressed partner caregivers in a randomized trial ( Clinicaltrials.gov ID: NCT04610034). Methods: Participants were recruited through an oncology department and two cancer counseling centers in Denmark. Partners of patients receiving cancer treatment and experiencing distress (> 4 on the distress thermometer) were eligible and randomized 1:1 to either the intervention or usual care, stratified by sex and age (≤/> 50 years). “Resilient Caregivers” consists of seven manualized sessions developed according to a resilience framework focusing on meta‐reflective skills, coping strategies and values clarification in relation to being a partner of a patient with cancer. Participants completed questionnaires at baseline, 3‐, 6‐ and 12‐months assessing anxiety (primary outcome) and depression, distress, stress, resilience, quality of life and sleep quality. Intervention effects were analyzed using mixed models for repeated measures. Results: Between April 2021 and May 2023, 79 partners were included (39 intervention, 40 control). Most were female (74%), above 50 years old (80%) and had at least a bachelor's degree (86%). There were significant improvements in anxiety at 12 months (mean difference: −2.5, 95% confidence interval: −4.6 to −0.4, p = 0.018), and depression and quality of life at 3 months. Between‐group differences were not significant for other outcomes. Satisfaction was high and participants valued the group format. Conclusions: “Resilient Caregivers” showed encouraging findings and may be a potentially cost‐effective approach to providing support to partner caregivers.
- 17 July 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (8) , 772
Which resilience-related factors are important for anxiety, depression, and stress in cancer caregivers?
Purpose Spousal caregivers provide critical support for cancer patients but are at high risk for adverse psychological outcomes. We aimed to investigate the associations between resilience and factors related to resilience in partner caregivers with caregiver anxiety, depression, and perceived stress. Methods This cross-sectional study used baseline data from the “Resilient Caregivers” randomized trial testing a resilience-based group intervention in distressed spousal cancer caregivers. Participants were spouses of cancer patients undergoing treatment (regardless of stage and type) and scored ≥ 4 on the Distress Thermometer. All participants completed questionnaires assessing resilience, social support, valued living, rumination, attention to threat, coping behaviors, metacognitive beliefs, anxiety, depression, and perceived stress. Results Seventy-nine spouses of cancer patients undergoing treatment were included, with the majority being female (75%), over 50 years old (80%), and with at least an undergraduate education (86%). Obstruction to valued living, rumination, and attention to threat were significantly negatively correlated with resilience (p ≤ 0.05). Low resilience, obstruction to valued living, rumination, and attention to threat were significantly associated with anxiety, depression, and perceived stress (p ≤ 0.01), while maladaptive coping was significantly associated with depression and perceived stress (p ≤ 0.05) and maladaptive metacognitive beliefs were significantly associated with anxiety (p = 0.03). Conclusions We found that obstruction to valued living, rumination, and attention to threat were associated with lower resilience and higher levels of anxiety, depression, and stress. These factors may be potential targets in future interventions to strengthen caregiver resilience and improve psychological outcomes among spousal caregivers.
- 17 July 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (8) , 772
Which resilience-related factors are important for anxiety, depression, and stress in cancer caregivers?
Purpose Spousal caregivers provide critical support for cancer patients but are at high risk for adverse psychological outcomes. We aimed to investigate the associations between resilience and factors related to resilience in partner caregivers with caregiver anxiety, depression, and perceived stress. Methods This cross-sectional study used baseline data from the “Resilient Caregivers” randomized trial testing a resilience-based group intervention in distressed spousal cancer caregivers. Participants were spouses of cancer patients undergoing treatment (regardless of stage and type) and scored ≥ 4 on the Distress Thermometer. All participants completed questionnaires assessing resilience, social support, valued living, rumination, attention to threat, coping behaviors, metacognitive beliefs, anxiety, depression, and perceived stress. Results Seventy-nine spouses of cancer patients undergoing treatment were included, with the majority being female (75%), over 50 years old (80%), and with at least an undergraduate education (86%). Obstruction to valued living, rumination, and attention to threat were significantly negatively correlated with resilience (p ≤ 0.05). Low resilience, obstruction to valued living, rumination, and attention to threat were significantly associated with anxiety, depression, and perceived stress (p ≤ 0.01), while maladaptive coping was significantly associated with depression and perceived stress (p ≤ 0.05) and maladaptive metacognitive beliefs were significantly associated with anxiety (p = 0.03). Conclusions We found that obstruction to valued living, rumination, and attention to threat were associated with lower resilience and higher levels of anxiety, depression, and stress. These factors may be potential targets in future interventions to strengthen caregiver resilience and improve psychological outcomes among spousal caregivers.
- Open Access
- 17 February 2025
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 64, 284-291
Fidelity of the Guided Self-Determination program in the MyHealth study during breast cancer follow-up
Background and purpose: MyHealth is a new follow-up program including individual nurse-led sessions based on Guided Self-Determination (GSD), which has been shown to improve health and psychological outcomes in patients after treatment for breast cancer. Fidelity assessment is important to support the implementation of GSD in clinical practice. The purpose of this study was thus to investigate fidelity and acceptance of the GSD program in the MyHealth study and whether sociodemographic and psychological factors were associated with patients’ completion of the GSD program and completion of reflection sheets. Material and methods: We assessed fidelity quantitatively by examining patients’ completion of the GSD program (i.e. ≥3 sessions), completion of the reflection sheets and their associations with sociodemographic and psychological factors among 239 patients, and nurse-reported acceptance qualitatively through a focus group interview with all five nurses providing the GSD program. Results: A total of 81% of patients completed the GSD program, while 71% of the reflection sheets were completed. Including a relative in a GSD session and lower education were significantly associated with completion of the program. Younger age and including a relative in a GSD session were significantly associated with completion of reflection sheets. Nurses found GSD highly applicable and especially appreciated a values-clarifying GSD reflection sheet and the inclusion of a relative. Interpretation: The GSD program was applied with moderate-to-high fidelity, and the inclusion of relatives is potentially valuable. The GSD program indicates high usability and potential for being translated into clinical practice.
- 17 February 2025
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 64, 284-291
Open AccessFidelity of the Guided Self-Determination program in the MyHealth study during breast cancer follow-up
Background and purpose: MyHealth is a new follow-up program including individual nurse-led sessions based on Guided Self-Determination (GSD), which has been shown to improve health and psychological outcomes in patients after treatment for breast cancer. Fidelity assessment is important to support the implementation of GSD in clinical practice. The purpose of this study was thus to investigate fidelity and acceptance of the GSD program in the MyHealth study and whether sociodemographic and psychological factors were associated with patients’ completion of the GSD program and completion of reflection sheets. Material and methods: We assessed fidelity quantitatively by examining patients’ completion of the GSD program (i.e. ≥3 sessions), completion of the reflection sheets and their associations with sociodemographic and psychological factors among 239 patients, and nurse-reported acceptance qualitatively through a focus group interview with all five nurses providing the GSD program. Results: A total of 81% of patients completed the GSD program, while 71% of the reflection sheets were completed. Including a relative in a GSD session and lower education were significantly associated with completion of the program. Younger age and including a relative in a GSD session were significantly associated with completion of reflection sheets. Nurses found GSD highly applicable and especially appreciated a values-clarifying GSD reflection sheet and the inclusion of a relative. Interpretation: The GSD program was applied with moderate-to-high fidelity, and the inclusion of relatives is potentially valuable. The GSD program indicates high usability and potential for being translated into clinical practice.
- Open Access
- 9 February 2025
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 64, 222-228
SleepNow – A combined cognitive behavioral therapy for insomnia and physical exercise intervention in men with metastatic prostate cancer: results from a feasibility randomized controlled trial
Focused on patients living with metastatic cancer. We examined the feasibility of the SleepNow intervention combining cognitive behavioral therapy for insomnia (CBT-I) with physical exercise in men with metastatic prostate cancer (mPCa). Patients/material and methods: We conducted a feasibility randomized trial in patients under treatment for castration resistant mPCa with insomnia (Insomnia Severity Index [ISI] score ≥ 8). Patients were randomized 1:1 to either SleepNow or usual care. SleepNow is a manualized 12-week program consisting of bi-weekly sessions of physical exercise and four nurse-led sessions of CBT-I. Patients in usual care received no insomnia treatment. We assessed feasibility and measured objective and patient-reported outcomes at baseline and 3-months follow-up. Changes in both groups were compared using the Wilcoxon test. Results: We randomized 12 patients (5 intervention and 7 control; age range = 59–81 years, mean Gleason score = 7.75, mean time since diagnosis ≈ 7 years). Intervention patients reported high satisfaction, all attended at least three CBT-I sessions (75%) and four completed at least 20 of the 24 training sessions. The intervention group showed improvements in insomnia, sleep quality, fatigue, anxiety, depression and health-related quality-of-life but between-group differences were not statistically significant. Interpretation: The SleepNow intervention is the first to combine nurse-delivered CBT-I and physical exercise and was acceptable and potentially efficacious. Our results are important for targeting sleep interventions to the growing population of patients living long term with metastatic cancer.
- 9 February 2025
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 64, 222-228
Open AccessSleepNow – A combined cognitive behavioral therapy for insomnia and physical exercise intervention in men with metastatic prostate cancer: results from a feasibility randomized controlled trial
Focused on patients living with metastatic cancer. We examined the feasibility of the SleepNow intervention combining cognitive behavioral therapy for insomnia (CBT-I) with physical exercise in men with metastatic prostate cancer (mPCa). Patients/material and methods: We conducted a feasibility randomized trial in patients under treatment for castration resistant mPCa with insomnia (Insomnia Severity Index [ISI] score ≥ 8). Patients were randomized 1:1 to either SleepNow or usual care. SleepNow is a manualized 12-week program consisting of bi-weekly sessions of physical exercise and four nurse-led sessions of CBT-I. Patients in usual care received no insomnia treatment. We assessed feasibility and measured objective and patient-reported outcomes at baseline and 3-months follow-up. Changes in both groups were compared using the Wilcoxon test. Results: We randomized 12 patients (5 intervention and 7 control; age range = 59–81 years, mean Gleason score = 7.75, mean time since diagnosis ≈ 7 years). Intervention patients reported high satisfaction, all attended at least three CBT-I sessions (75%) and four completed at least 20 of the 24 training sessions. The intervention group showed improvements in insomnia, sleep quality, fatigue, anxiety, depression and health-related quality-of-life but between-group differences were not statistically significant. Interpretation: The SleepNow intervention is the first to combine nurse-delivered CBT-I and physical exercise and was acceptable and potentially efficacious. Our results are important for targeting sleep interventions to the growing population of patients living long term with metastatic cancer.
- Open Access
- 8 January 2025
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 64, 34-39
Work ability following breast cancer – the MyHealth randomized controlled trial
Background and purpose: We previously demonstrated positive effects on quality of life and mental health following breast cancer when comparing a nurse-led follow-up program without scheduled visits (MyHealth) to regular follow-up. This study aims to examine whether MyHealth also positively impacts self-reported work ability. Patients/material and methods: A total of 288 patients, potentially active on the labour market, were randomized to MyHealth or control follow-up after primary treatment for early-stage breast cancer (2017–2019). MyHealth included individual self-management sessions, electronic symptom monitoring, and assistance with navigating healthcare services. Control follow-up consisted of biannual outpatient visits with a physician. Linear mixed-effect models were applied to evaluate the effect of MyHealth on self-reported work ability at 6, 12, 24, and 36 months after randomization as measured by the Work Ability Score (WAS). Results: Work ability increased significantly in both groups during the first 6 months (mean WAS increase MyHealth: 1.64, 95% confidence interval [CI]: 1.26; 2.02 and control: 1.57, 95% CI: 1.17; 1.97) and continued to increase slightly but non-significantly (p-values > 0.13) until end of follow-up at 36 months. Improvement was especially pronounced among patients reporting poor work ability at baseline. Differences in mean WAS between patients in MyHealth and control follow-up were non-significant and close to zero at all time points (–0.21 to 0.48). Interpretation: The MyHealth follow-up program had no additional effect on self-reported work ability compared to regular follow-up. Future interventions should target patients with poor work ability and include components specifically designed to enhance work ability.
- 8 January 2025
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 64, 34-39
Open AccessWork ability following breast cancer – the MyHealth randomized controlled trial
Background and purpose: We previously demonstrated positive effects on quality of life and mental health following breast cancer when comparing a nurse-led follow-up program without scheduled visits (MyHealth) to regular follow-up. This study aims to examine whether MyHealth also positively impacts self-reported work ability. Patients/material and methods: A total of 288 patients, potentially active on the labour market, were randomized to MyHealth or control follow-up after primary treatment for early-stage breast cancer (2017–2019). MyHealth included individual self-management sessions, electronic symptom monitoring, and assistance with navigating healthcare services. Control follow-up consisted of biannual outpatient visits with a physician. Linear mixed-effect models were applied to evaluate the effect of MyHealth on self-reported work ability at 6, 12, 24, and 36 months after randomization as measured by the Work Ability Score (WAS). Results: Work ability increased significantly in both groups during the first 6 months (mean WAS increase MyHealth: 1.64, 95% confidence interval [CI]: 1.26; 2.02 and control: 1.57, 95% CI: 1.17; 1.97) and continued to increase slightly but non-significantly (p-values > 0.13) until end of follow-up at 36 months. Improvement was especially pronounced among patients reporting poor work ability at baseline. Differences in mean WAS between patients in MyHealth and control follow-up were non-significant and close to zero at all time points (–0.21 to 0.48). Interpretation: The MyHealth follow-up program had no additional effect on self-reported work ability compared to regular follow-up. Future interventions should target patients with poor work ability and include components specifically designed to enhance work ability.
- 10 June 2024
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 42 (17) , 2038-2049
Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial
PURPOSE: Follow-up after breast cancer with regular visits has failed to detect recurrences, be cost-effective, and address patient needs. METHODS: MyHealth is a phase III randomized controlled trial (ClinicalTrials.gov identifier: NCT02949167 ). Patients, who recently completed primary treatment for stage I-II breast cancer, were randomly assigned in variable block sizes and stratified by age and human epidermal growth factor receptor 2 status to intervention or control follow-up. The nurse-led intervention comprised three to five individual self-management sessions, regular reporting of symptoms, and navigation to health care services. The control follow-up comprised regular outpatient visits with the physician. The primary outcome was breast cancer–specific quality of life (QoL) measured by the Trial Outcome Index-Physical/Functional/Breast summary score of the Functional Assessment of Cancer Therapy-Breast 2 years after random assignment. Secondary outcomes were fear of recurrence, anxiety, depression, and health care utilization. Analyses were intention-to-treat and P values were two-sided with 95% confidence level set at 0.005 because of multiple comparisons. RESULTS: Among 1,101 eligible patients, 875 were invited and 503 were randomly assigned to control (n = 252) or intervention (n = 251) follow-up. At 2 years, patients in the intervention group reported a significantly and clinically relevant higher QoL (mean, 75.69 [standard deviation [SD], 12.27]) than patients in the control group (71.26 [SD, 14.08]), with a mean difference of 5.05 (95% CI, 3.30 to 6.79; P < .001). The intervention group reported significantly less fear of recurrence, anxiety, and depression; they had fewer physician consultations but more nurse contacts and an unchanged diagnostic imaging pattern. The effect on all outcomes was stable through a 3-year follow-up. CONCLUSION: The MyHealth study suggested a new strategy for follow-up after early breast cancer as it provided significant improvements in QoL.
- 10 June 2024
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 42 (17) , 2038-2049
Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial
PURPOSE: Follow-up after breast cancer with regular visits has failed to detect recurrences, be cost-effective, and address patient needs. METHODS: MyHealth is a phase III randomized controlled trial (ClinicalTrials.gov identifier: NCT02949167 ). Patients, who recently completed primary treatment for stage I-II breast cancer, were randomly assigned in variable block sizes and stratified by age and human epidermal growth factor receptor 2 status to intervention or control follow-up. The nurse-led intervention comprised three to five individual self-management sessions, regular reporting of symptoms, and navigation to health care services. The control follow-up comprised regular outpatient visits with the physician. The primary outcome was breast cancer–specific quality of life (QoL) measured by the Trial Outcome Index-Physical/Functional/Breast summary score of the Functional Assessment of Cancer Therapy-Breast 2 years after random assignment. Secondary outcomes were fear of recurrence, anxiety, depression, and health care utilization. Analyses were intention-to-treat and P values were two-sided with 95% confidence level set at 0.005 because of multiple comparisons. RESULTS: Among 1,101 eligible patients, 875 were invited and 503 were randomly assigned to control (n = 252) or intervention (n = 251) follow-up. At 2 years, patients in the intervention group reported a significantly and clinically relevant higher QoL (mean, 75.69 [standard deviation [SD], 12.27]) than patients in the control group (71.26 [SD, 14.08]), with a mean difference of 5.05 (95% CI, 3.30 to 6.79; P < .001). The intervention group reported significantly less fear of recurrence, anxiety, and depression; they had fewer physician consultations but more nurse contacts and an unchanged diagnostic imaging pattern. The effect on all outcomes was stable through a 3-year follow-up. CONCLUSION: The MyHealth study suggested a new strategy for follow-up after early breast cancer as it provided significant improvements in QoL.
- 4 March 2024
- Published by SAGE Publications in Palliative Medicine
- Vol. 38 (3) , 389-395
Improving family grief outcomes: A scoping review of family-based interventions before and after the death of a child
Background: Experiencing the illness and death of a child is a traumatic experience for the parents and the child’s siblings. However, knowledge regarding effective grief interventions targeting the whole family is limited, including how to integrate age-appropriate support for siblings. Aim: We aimed to synthesize the empirical literature regarding grief interventions that target the whole family before and/or after the death of a child. Design: A scoping review following the Joanna Briggs Institute and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. Data sources: We searched PubMed, PsycINFO, Embase, CINAHL, and Scopus covering January 1998–May 2022. We included studies describing any type of structured intervention targeting the whole family (i.e. parents and siblings) before or/and after the death of a child (below 18 years), with pre-post assessments of grief-related symptoms in the family as an outcome. Results: After removal of duplicates, we screened the titles and abstracts of 4078 publications and identified 30 publications for full-text screening. None of the studies met the inclusion criteria. Most of the studies were excluded because they either did not target the whole family or did not target families who had lost a child below 18 years. Bereavement camps were a popular form of family intervention, but none were evaluated in a pre-post design. No grief interventions offering support pre-death were found. Conclusions: There is great need for research to improve bereavement outcomes for the entire family and to potentially integrate this in pediatric palliative care.
- 4 March 2024
- Published by SAGE Publications in Palliative Medicine
- Vol. 38 (3) , 389-395
Improving family grief outcomes: A scoping review of family-based interventions before and after the death of a child
Background: Experiencing the illness and death of a child is a traumatic experience for the parents and the child’s siblings. However, knowledge regarding effective grief interventions targeting the whole family is limited, including how to integrate age-appropriate support for siblings. Aim: We aimed to synthesize the empirical literature regarding grief interventions that target the whole family before and/or after the death of a child. Design: A scoping review following the Joanna Briggs Institute and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. Data sources: We searched PubMed, PsycINFO, Embase, CINAHL, and Scopus covering January 1998–May 2022. We included studies describing any type of structured intervention targeting the whole family (i.e. parents and siblings) before or/and after the death of a child (below 18 years), with pre-post assessments of grief-related symptoms in the family as an outcome. Results: After removal of duplicates, we screened the titles and abstracts of 4078 publications and identified 30 publications for full-text screening. None of the studies met the inclusion criteria. Most of the studies were excluded because they either did not target the whole family or did not target families who had lost a child below 18 years. Bereavement camps were a popular form of family intervention, but none were evaluated in a pre-post design. No grief interventions offering support pre-death were found. Conclusions: There is great need for research to improve bereavement outcomes for the entire family and to potentially integrate this in pediatric palliative care.
- Open Access
- 7 December 2023
- Published by Springer Nature in Research Involvement and Engagement
- Vol. 9 (1) , 1-13
Patient Engagement in Research Scale (PEIRS-22): Danish translation, applicability, and user experiences
Background: Patient and Public Involvement (PPI) in health research is gaining increased attention and acceptance worldwide. Reliable measurements are crucial to accurately assess, monitor, and evaluate patient involvement efforts in research. The Patient Engagement in Research Scale (PEIRS-22) measures meaningful patient and family caregiver engagement in research. This study focuses on three primary objectives: (1) translation of the PEIRS-22 from English to Danish, followed by linguistic validation and cultural adaptation; (2) assessing the applicability of the Danish PEIRS-22; and (3) focus group interviews to explore the user experiences of PPI. Methods: A three-phase multi-method study was conducted. In phase one, the PEIRS-22 was translated, linguistically validated and culturally adapted to Danish. In phase two individuals from three distinct patient cancer advisory boards responded to the Danish version of PEIRS-22 to assess its applicability. Three focus group interviews were conducted in phase three, involving individuals from three patient cancer advisory boards. Results: The translation process resulted in a Danish version of PEIRS-22, conceptually and culturally equivalent to the English version. Overall, among individuals of the three advisory boards (n = 15) the applicability was found to be satisfactory, with no missing data and all items completed. The total PEIRS-22 score among the three advisory boards was 85.2 out of a possible 100, with higher scores indicating greater meaningful involvement. A nested sample of the three patient cancer advisory boards (n = 9) participated in focus group interviews. The analysis yielded four themes: (1) The Danish PEIRS-22 captured the intended cultural meaning and contributed to self-reflection, (2) Internal motivation is a driver for involvement (3), Involvement brought a personal sense of empowerment and (4) Meaningful involvement collaborations are fostered by a trustful atmosphere. Conclusions: The PEIRS-22 questionnaire has been translated, linguistically validated, and culturally adapted into Danish. We propose that the PEIRS-22 is now ready for use in Danish populations. This study provides a Danish version of the questionnaire that can be used to develop patient-centred practices and foster meaningful involvement and collaborations between patients and researchers in the field of cancer research in Denmark. Personal benefits of participating in PPI can vary, and we recommend using PEIRS-22 in conjunction with a qualitative approach to better explore perspectives on meaningful involvement. Trial registration: The study was registered prospectively on October 22, 2022, by the Danish Data Protection Agency (jr. nr. P-2022–528).
- 7 December 2023
- Published by Springer Nature in Research Involvement and Engagement
- Vol. 9 (1) , 1-13
Open AccessPatient Engagement in Research Scale (PEIRS-22): Danish translation, applicability, and user experiences
Background: Patient and Public Involvement (PPI) in health research is gaining increased attention and acceptance worldwide. Reliable measurements are crucial to accurately assess, monitor, and evaluate patient involvement efforts in research. The Patient Engagement in Research Scale (PEIRS-22) measures meaningful patient and family caregiver engagement in research. This study focuses on three primary objectives: (1) translation of the PEIRS-22 from English to Danish, followed by linguistic validation and cultural adaptation; (2) assessing the applicability of the Danish PEIRS-22; and (3) focus group interviews to explore the user experiences of PPI. Methods: A three-phase multi-method study was conducted. In phase one, the PEIRS-22 was translated, linguistically validated and culturally adapted to Danish. In phase two individuals from three distinct patient cancer advisory boards responded to the Danish version of PEIRS-22 to assess its applicability. Three focus group interviews were conducted in phase three, involving individuals from three patient cancer advisory boards. Results: The translation process resulted in a Danish version of PEIRS-22, conceptually and culturally equivalent to the English version. Overall, among individuals of the three advisory boards (n = 15) the applicability was found to be satisfactory, with no missing data and all items completed. The total PEIRS-22 score among the three advisory boards was 85.2 out of a possible 100, with higher scores indicating greater meaningful involvement. A nested sample of the three patient cancer advisory boards (n = 9) participated in focus group interviews. The analysis yielded four themes: (1) The Danish PEIRS-22 captured the intended cultural meaning and contributed to self-reflection, (2) Internal motivation is a driver for involvement (3), Involvement brought a personal sense of empowerment and (4) Meaningful involvement collaborations are fostered by a trustful atmosphere. Conclusions: The PEIRS-22 questionnaire has been translated, linguistically validated, and culturally adapted into Danish. We propose that the PEIRS-22 is now ready for use in Danish populations. This study provides a Danish version of the questionnaire that can be used to develop patient-centred practices and foster meaningful involvement and collaborations between patients and researchers in the field of cancer research in Denmark. Personal benefits of participating in PPI can vary, and we recommend using PEIRS-22 in conjunction with a qualitative approach to better explore perspectives on meaningful involvement. Trial registration: The study was registered prospectively on October 22, 2022, by the Danish Data Protection Agency (jr. nr. P-2022–528).
- 25 September 2023
- Published by Wiley in Psycho-Oncology
- Vol. 32 (11) , 1684-1693
Psychosocial care for cancer survivors: A global review of national cancer control plans
Objective: National Cancer Control Plans (NCCPs) are high‐level policy documents that prioritise actions to be taken to improve cancer control activities. As the number of cancer survivors grows globally, there is an urgent need to assess whether and how psychosocial care across the cancer care continuum is included in NCCPs. This review aimed to ascertain the extent to which NCCPs referenced psycho‐oncology care for cancer survivors in the post‐treatment phase.Methods: NCCPs were obtained from the International Cancer Control Partnership (ICCP) portal (in November 2021) and reviewed in two phases. In Phase 1, all available NCCPs were screened to determine whether they mentioned psycho‐oncology or survivorship. In Phase 2, reviewers extracted data from the NCCPs identified in Phase 1 on the degree that each plan articulated objectives/goals to improve psychosocial care in the post‐treatment survivorship phase.Results: We screened 237 NCCPs. Of these, initial potential reference to psycho‐oncology and survivorship content were identified in 97 plans (41%). In Phase 1, 57/97 (59%) had reference to psycho‐oncology or survivorship content within defined criteria. In Phase 2, 27/97 (28%) had little mention of psycho‐oncology specifically in survivorship, 47/97 (48%) had some (general or brief) mention, and the remaining 23/97 (24%) had substantial content/specific sections and clearly articulated goals and/or objectives. Common goals for improving psychosocial care in the post‐treatment period included building capacity of healthcare professionals, implementing rehabilitation models, and increasing the utilisation of community services.Conclusions: Most NCCPs did not reference psycho‐oncology and only one‐quarter contained clear objectives specifically in the post‐treatment survivorship phase.
- 25 September 2023
- Published by Wiley in Psycho-Oncology
- Vol. 32 (11) , 1684-1693
Psychosocial care for cancer survivors: A global review of national cancer control plans
Objective: National Cancer Control Plans (NCCPs) are high‐level policy documents that prioritise actions to be taken to improve cancer control activities. As the number of cancer survivors grows globally, there is an urgent need to assess whether and how psychosocial care across the cancer care continuum is included in NCCPs. This review aimed to ascertain the extent to which NCCPs referenced psycho‐oncology care for cancer survivors in the post‐treatment phase.Methods: NCCPs were obtained from the International Cancer Control Partnership (ICCP) portal (in November 2021) and reviewed in two phases. In Phase 1, all available NCCPs were screened to determine whether they mentioned psycho‐oncology or survivorship. In Phase 2, reviewers extracted data from the NCCPs identified in Phase 1 on the degree that each plan articulated objectives/goals to improve psychosocial care in the post‐treatment survivorship phase.Results: We screened 237 NCCPs. Of these, initial potential reference to psycho‐oncology and survivorship content were identified in 97 plans (41%). In Phase 1, 57/97 (59%) had reference to psycho‐oncology or survivorship content within defined criteria. In Phase 2, 27/97 (28%) had little mention of psycho‐oncology specifically in survivorship, 47/97 (48%) had some (general or brief) mention, and the remaining 23/97 (24%) had substantial content/specific sections and clearly articulated goals and/or objectives. Common goals for improving psychosocial care in the post‐treatment period included building capacity of healthcare professionals, implementing rehabilitation models, and increasing the utilisation of community services.Conclusions: Most NCCPs did not reference psycho‐oncology and only one‐quarter contained clear objectives specifically in the post‐treatment survivorship phase.